...
首页> 外文期刊>Crystals >From Initial Hit to Crystal Optimization with Microseeding of Human Carbonic Anhydrase IX—A Case Study for Neutron Protein Crystallography
【24h】

From Initial Hit to Crystal Optimization with Microseeding of Human Carbonic Anhydrase IX—A Case Study for Neutron Protein Crystallography

机译:从最初的命中到人类碳酸酐酶IX微晶的晶体优化-以中子蛋白质晶体学为例

获取原文
           

摘要

Human carbonic anhydrase IX (CA IX) is a multi-domain membrane protein that is therefore difficult to express or crystalize. To prepare crystals that are suitable for neutron studies, we are using only the catalytic domain of CA IX with six surface mutations, named surface variant (SV). The crystallization of CA IX SV, and also partly deuterated CA IX SV, was enabled by the use of microseed matrix screening (MMS). Only three drops with crystals were obtained after initial sparse matrix screening, and these were used as seeds in subsequent crystallization trials. Application of MMS, commercial screens, and refinement resulted in consistent crystallization and diffraction-quality crystals. The crystallization protocols and strategies that resulted in consistent crystallization are presented. These results demonstrate not only the use of MMS in the growth of large single crystals for neutron studies with defined conditions, but also that MMS enabled re-screening to find new conditions and consistent crystallization success.
机译:人碳酸酐酶IX(CA IX)是一种多域膜蛋白,因此难以表达或结晶。为了制备适合中子研究的晶体,我们仅使用具有六个表面突变的CA IX的催化结构域,称为表面变体(SV)。 CA IX SV的结晶以及CA IX SV的部分氘化通过使用微种子基质筛选(MMS)得以实现。在最初的稀疏基质筛选之后,仅获得了三滴带有晶体的液滴,并将其用作随后的结晶试验的种子。 MMS的应用,商业筛选和提纯导致晶体结晶和衍射质量一致。介绍了导致一致结晶的结晶方案和策略。这些结果不仅证明了在限定条件下的中子研究中,在大型单晶生长中使用了MMS,而且MMS能够重新筛选以发现新的条件并获得稳定的结晶成功。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号